Inhibition Effect of STING Agonist SR717 on PRRSV Replication

Xuanying Si,Xiaoge Wang,Hongju Wu,Zhiwei Yan,Longqi You,Geng Liu,Mao Cai,Angke Zhang,Juncheng Liang,Guoyu Yang,Chen Yao,Yongkun Du
DOI: https://doi.org/10.3390/v16091373
2024-08-31
Viruses
Abstract:The porcine reproductive and respiratory syndrome virus (PRRSV) belongs to the Arteriviridae family and is a single-stranded, positively stranded RNA virus. The currently available PRRSV vaccines are mainly inactivated and attenuated vaccines, yet none of the commercial vaccines can provide comprehensive, long-lasting, and effective protection against PRRSV. SR717 is a pyridazine-3-carboxamide compound, which is commonly used as a non-nucleoside STING agonist with antitumor and antiviral activities. Nevertheless, there is no evidence that SR717 has any antiviral effects against PRRSV. In this study, a dose-dependent inhibitory effect of SR717 was observed against numerous strains of PRRSV using qRT-PCR, IFA, and WB methods. Furthermore, SR717 was found to stimulate the production of anti-viral molecules and trigger the activation of the signaling cascade known as the stimulator of interferon genes (STING) pathway, which contributed to hindering the reproduction of viruses by a certain margin. Collectively, these results indicate that SR717 is capable of inhibiting PRRSV infection in vitro and may have potential as an antiviral drug against PRRSV.
virology
What problem does this paper attempt to address?